There's studies showing that rifaxamin which is an antibiotic that treats bacterial overgrowth in the small intestine reduces serum TMAO levels.

相关研究显示，利福昔明（rifaxamin）这种用于治疗小肠内细菌过度生长的抗生素能降低人体内的血清氧化三甲胺水平。